Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

Activating ER-β, not ER-α, improves skin cell growth and wound healing.

The woman had a rare adrenal tumor removed, and she recovered well with no signs of the tumor returning.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Reduced sexual drive may be linked to male breast cancer, while anti-estrogenic factors might lower the risk.

Women with pituitary adenomas often have reproductive issues, like irregular periods and trouble getting pregnant, but not always breast milk production without pregnancy.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Low-dose finasteride can cause painful breast enlargement in men, which resolves after stopping the medication.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

Hyperprolactinemia is the most common cause of secondary amenorrhea, followed by drug use.

Idiopathic hirsutism may be linked to increased skin enzyme activity, and new treatments like laser and eflornithine cream show promise.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Prostate cancer risk is not linked to blood testosterone levels.

Exogenous testosterone use may be linked to developing hidradenitis suppurativa.

Hormonal imbalances, especially high androgen levels and insulin resistance, are linked to worse acne in adult women.

Local estrogen synthesis in skin may improve wound healing.

Most adult females with acne do not have hormonal imbalances, but some show signs of excess male hormones.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Higher DHEAS levels may cause hair loss in women by disrupting hair growth.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

Prolactin levels are higher in women with hirsutism but don't relate to its severity.

Most women with hirsutism have normal hormone levels and can be treated with cosmetic methods; obesity and PCOS are common causes, and treatments depend on the underlying issue.

Spironolactone may help reduce excessive hair growth in women with high male hormone levels.

Hirsutism in GCC countries is influenced by genetics, obesity, and lifestyle, with cultural stigma delaying treatment, highlighting the need for tailored health strategies.

Finasteride can cause muscle pain and high creatine kinase levels, but stopping the medication may resolve symptoms.

Steroid cell tumors in ovaries are rare, can cause hormone changes, and may be cancerous.

The document concludes that more research is needed to create suitable diagnostic criteria and understand PCOS in Korean women, and genetics may allow for personalized treatment.